Hector H Garcia Selected Research

Neurocysticercosis

1/2022	A recombinant monoclonal-based Taenia antigen assay that reflects disease activity in extra-parenchymal neurocysticercosis.
1/2022	Improved Diagnosis of Viable Parenchymal Neurocysticercosis by Combining Antibody Banding Patterns on Enzyme-Linked Immunoelectrotransfer Blot (EITB) with Antigen Enzyme-Linked Immunosorbent Assay (ELISA).
1/2022	Proliferative cells in racemose neurocysticercosis have an active MAPK signalling pathway and respond to metformin treatment.
12/2021	Advances in the treatment, diagnosis, control and scientific understanding of taeniid cestode parasite infections over the past 50 years.
10/2020	Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study.
1/2020	Population Screening for Urine Antigens to Detect Asymptomatic Subarachnoid Neurocysticercosis: A Pilot Study in Northern Peru.
11/2019	Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
1/2019	Detection of Taenia solium DNA in the Urine of Neurocysticercosis Patients.
1/2019	Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study.
5/2018	Inflammation is a key risk factor for persistent seizures in neurocysticercosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hector H Garcia Research Topics

Disease

35	Neurocysticercosis 01/2022 - 10/2003
33	Cysticercosis 01/2022 - 10/2003
30	Cysts 01/2022 - 10/2003
16	Infections 01/2022 - 09/2004
12	Echinococcosis (Hydatid Cysts) 12/2021 - 10/2003
12	Taeniasis 01/2021 - 10/2003
11	Seizures (Absence Seizure) 11/2021 - 01/2005
7	Inflammation (Inflammations) 01/2020 - 10/2003
5	Epilepsy (Aura) 01/2020 - 09/2011
3	Edema (Dropsy) 02/2015 - 01/2005
2	Neoplasms (Cancer) 05/2022 - 01/2021
2	Parasitic Diseases (Parasitic Disease) 01/2019 - 06/2005
2	Body Weight (Weight, Body) 01/2019 - 01/2016
2	Cestode Infections (Tapeworm Infection) 10/2014 - 06/2004
2	Tuberculosis (Tuberculoses) 08/2010 - 01/2005
1	Communicable Diseases (Infectious Diseases) 05/2022
1	Central Nervous System Cysts (Suprasellar Cyst) 01/2022
1	Immune Reconstitution Inflammatory Syndrome 10/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Temporal Lobe Epilepsy 01/2020
1	Hepatic Echinococcosis 01/2019
1	Trematode Infections (Fasciolopsiasis) 01/2019
1	Anemia 11/2012
1	Megaloblastic Anemia 11/2012
1	Atrophy 11/2012
1	Central Nervous System Infections (Central Nervous System Infection) 08/2012
1	Fascioliasis 03/2012
1	Granuloma 09/2011
1	Intracranial Hypertension 10/2010
1	Coinfection 08/2010
1	Encephalitis (Encephalitis, Rasmussen) 06/2006
1	Tuberculoma 01/2005
1	Cicatrix (Scar) 10/2003

Drug/Important Bio-Agent (IBA)

25	AntigensIBA 01/2022 - 10/2003
19	Antiparasitic Agents (Antiparasitics)IBA 01/2022 - 10/2003
18	EnzymesIBA 01/2022 - 09/2004
14	AntibodiesIBA 01/2018 - 10/2003
12	Albendazole (Albenza)FDA Link 11/2021 - 02/2006
9	Praziquantel (Biltricide)FDA Link 12/2021 - 06/2008
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2004
8	oxfendazoleIBA 10/2020 - 09/2004
7	ImmunosorbentsIBA 01/2022 - 09/2004
7	lentil lectinIBA 01/2019 - 09/2004
7	Glycoproteins (Glycoprotein)IBA 01/2019 - 09/2004
5	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 09/2012
5	brain synaptic membrane glycoprotein gp 50 (GP50)IBA 01/2019 - 01/2010
4	Niclosamide FDA Link 01/2021 - 03/2004
4	Pharmaceutical PreparationsIBA 01/2016 - 06/2008
4	Recombinant ProteinsIBA 05/2014 - 06/2004
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 02/2015
3	AnthelminticsIBA 10/2020 - 08/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2008
3	nitazoxanide (NTZ)FDA Link 08/2012 - 02/2007
3	ChemokinesIBA 10/2010 - 09/2005
3	VaccinesIBA 12/2007 - 10/2003
2	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 09/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 08/2011
2	benzimidazoleIBA 10/2020 - 01/2019
2	Peptides (Polypeptides)IBA 05/2014 - 06/2012
2	Synthetic Vaccines (Recombinant Vaccines)IBA 04/2011 - 04/2006
1	Insulin ReceptorIBA 01/2022
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2022
1	Iron-Binding ProteinsIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	ferric ferrocyanide (Prussian blue)FDA Link 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	IronIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	BenzimidazolesIBA 12/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2020
1	albendazole sulfoxideIBA 11/2019
1	TriclabendazoleIBA 01/2016
1	SteroidsIBA 09/2014
1	Evans Blue (Blue, Evans)FDA Link 01/2014
1	Coloring Agents (Dyes)IBA 01/2014
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2012
1	Prednisone (Sone)FDA LinkGeneric 08/2012
1	Arecoline (Arecolin)IBA 01/2012
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 09/2011
1	Tuberculin (PPD)IBA 08/2010
1	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2008
1	NF-kappa B (NF-kB)IBA 06/2006
1	DisulfidesIBA 05/2006
1	EpitopesIBA 05/2006
1	Protons (Proton)IBA 01/2005
1	LipidsIBA 01/2005
1	CreatineIBA 01/2005
1	Choline (Choline Chloride)IBA 01/2005
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2005
1	Cathartics (Purgatives)IBA 03/2004

Therapy/Procedure

10	Therapeutics 10/2021 - 08/2010
5	Aftercare (After-Treatment) 01/2022 - 03/2004
2	Operative Surgical Procedures 01/2016 - 08/2012
1	Retreatment 11/2021
1	Mass Drug Administration 01/2021
1	Drug Therapy (Chemotherapy) 01/2016